Stocks
GlaxoSmithKline (GSK) FCF conversion US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| FCF conversion, % | 81.7% | 78.5% | 68.9% | 53.6% | 56.0% | 55.3% | |||
| Changes by years, y/y, % | +1pp | -3pp | -10pp | -15pp | +2pp | -7.0% | |||
GlaxoSmithKline. FCF conversion, %
GlaxoSmithKline. FCF conversion, changes, pp
GlaxoSmithKline (GSK) FCF conversion US GAAP (quarter values) |
||||||||
| FY2025Q4 | FY2025Q4 | FY2026Q1 | FY2026Q2 | FY2026Q2 | LTM ? | |||
| FCF conversion, % | 77.4% | 77.4% | 25.2% | 78.1% | 78.1% | 55.3% | ||
| Changes by years, y/y, % | -29pp | -29pp | +3pp | +33pp | +33pp | |||
| Changes by quarters, q/q, % | +0pp | 0pp | -52pp | +53pp | 0pp | |||
